Company Overview of Quark Pharmaceuticals, Inc.
Key Executives for Quark Pharmaceuticals, Inc.
|Daniel Zurr Ph.D.||20 Relationships||Founder, Chief Executive Officer, President and Director||70|
|Tomer Natan LLM, BB, CPA||No Relationships||Chief Financial Officer||--|
|Rami Skaliter Ph.D.||3 Relationships||Chief Operating Officer||58|
|Shai S. Erlich Ph.D.||No Relationships||Chief Medical Officer||50|
|Juliana Friedmann M.Sc.||No Relationships||Senior Vice President of Strategy & Planning||64|
Quark Pharmaceuticals, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Philip B. Simon J.D., CPA||20 Relationships||Lawrence Investments, LLC||63|
|Daniel Zurr Ph.D.||20 Relationships||Quark Pharmaceuticals, Inc.||70|
|Philip M. Hahn||20 Relationships||Quark Pharmaceuticals, Inc.||74|
|André G. Pernet Ph.D., M.B.A||44 Relationships||Genset Corporation||71|
|Dov Weinberger M.D.||20 Relationships||Quark Pharmaceuticals, Inc.||--|
Quark Pharmaceuticals, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Audit Committee J.D., CPA||Philip B. Simon||20 Relationships||1 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options||$457.3K|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.